project id: TCGA-OV; case submitter id: TCGA-13-1495; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22046; days to death: 2749; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1944; age at diagnosis: 22046; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1498.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 2.1; preservation method: Unknown; shortest dimension: 0.4; sample id: 98675894-f21c-4dc4-b822-a6e52634d470; sample submitter id: TCGA-13-1495-01A; portion id: 3a018c7b-3334-4c02-88cc-70e40ec30235; portion submitter id: TCGA-13-1495-01A-01; percent necrosis: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 79.0; percent tumor nuclei: 80.0;